Stay updated on Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe record history adds an entry stating recruitment is no longer open ('No longer looking for participants') and notes the revision to version v3.6.0, replacing the previous v3.5.5 revision.SummaryDifference0.4%

- Check10 days agoChange DetectedA new revision entry v3.5.5 was added to the history and the previous revision v3.5.4 was removed from the visible history, updating the revision log.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry v3.5.4 was added to the record history. The previous revision v3.5.3 was removed, signaling an update to the page’s versioning.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now reflects a newer ClinicalTrials.gov software/UI revision label (v3.5.3 instead of v3.5.2), which represents an internal version update rather than a change to the trial’s recorded information.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.